BG26387A3 - Метод за получаване на хексахидро- дибензо/вd/ пиран -9-они - Google Patents

Метод за получаване на хексахидро- дибензо/вd/ пиран -9-они

Info

Publication number
BG26387A3
BG26387A3 BG028125A BG2812574A BG26387A3 BG 26387 A3 BG26387 A3 BG 26387A3 BG 028125 A BG028125 A BG 028125A BG 2812574 A BG2812574 A BG 2812574A BG 26387 A3 BG26387 A3 BG 26387A3
Authority
BG
Bulgaria
Prior art keywords
hexachydro
dibenzo
pyran
obtaining
obtaining hexachydro
Prior art date
Application number
BG028125A
Other languages
Bulgarian (bg)
English (en)
Inventor
Robert Archer
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG26387A3 publication Critical patent/BG26387A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
BG028125A 1973-11-05 1974-11-05 Метод за получаване на хексахидро- дибензо/вd/ пиран -9-они BG26387A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/413,010 US3968125A (en) 1973-11-05 1973-11-05 Dihydroxyhexahydrodibenzo[b,d]pyrans

Publications (1)

Publication Number Publication Date
BG26387A3 true BG26387A3 (bg) 1979-03-15

Family

ID=23635420

Family Applications (1)

Application Number Title Priority Date Filing Date
BG028125A BG26387A3 (bg) 1973-11-05 1974-11-05 Метод за получаване на хексахидро- дибензо/вd/ пиран -9-они

Country Status (26)

Country Link
US (1) US3968125A (ko)
JP (1) JPS6033835B2 (ko)
AR (1) AR202318A1 (ko)
AT (1) AT336012B (ko)
BE (1) BE821716A (ko)
BG (1) BG26387A3 (ko)
CA (1) CA1023753A (ko)
CH (1) CH605894A5 (ko)
CS (1) CS193507B2 (ko)
DD (1) DD116230A5 (ko)
DE (1) DE2451934C2 (ko)
DK (1) DK136719B (ko)
ES (1) ES431674A1 (ko)
FR (1) FR2249664B1 (ko)
GB (1) GB1487637A (ko)
HU (1) HU169193B (ko)
IE (1) IE40023B1 (ko)
IL (1) IL45644A (ko)
NL (1) NL7414439A (ko)
PH (1) PH11788A (ko)
PL (2) PL95748B1 (ko)
RO (1) RO71766A (ko)
SE (1) SE415762B (ko)
SU (1) SU524517A3 (ko)
YU (1) YU36515B (ko)
ZA (1) ZA745751B (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6299930U (ko) * 1985-12-12 1987-06-25
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2130820A1 (en) 2002-02-19 2009-12-09 Shionogi & Co., Ltd. Antipruritics
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
US8829043B2 (en) 2008-02-08 2014-09-09 Nektar Therapeutics Oligome-cannabinoid conjugates
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP3654942A1 (en) 2017-07-20 2020-05-27 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Pharmaceutical film compositions for delivery of lipophilic compounds into and/or across the skin
EP3681474A1 (en) 2017-09-11 2020-07-22 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Compositions and methods for nasal administration of drugs to brain and for systemic effect
CA3116187A1 (en) 2017-11-29 2019-06-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cannabinoids compositions and methods
US20220008354A1 (en) 2018-11-04 2022-01-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Orally administrable cannabinoids-containing compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.

Also Published As

Publication number Publication date
GB1487637A (en) 1977-10-05
IE40023L (en) 1975-05-05
AU7321274A (en) 1976-03-18
IL45644A0 (en) 1974-11-29
DK136719C (ko) 1978-04-24
DK573274A (ko) 1975-07-07
CH605894A5 (ko) 1978-10-13
BE821716A (fr) 1975-04-30
CA1023753A (en) 1978-01-03
HU169193B (ko) 1976-10-28
IE40023B1 (en) 1979-02-28
PL95748B1 (pl) 1977-11-30
CS193507B2 (en) 1979-10-31
YU36515B (en) 1984-02-29
RO71766A (ro) 1982-12-06
DD116230A5 (ko) 1975-11-12
AR202318A1 (es) 1975-05-30
YU265874A (en) 1982-02-25
JPS6033835B2 (ja) 1985-08-05
SU524517A3 (ru) 1976-08-05
US3968125A (en) 1976-07-06
FR2249664A1 (ko) 1975-05-30
DE2451934A1 (de) 1975-05-07
PL93908B1 (ko) 1977-07-30
JPS5071678A (ko) 1975-06-13
FR2249664B1 (ko) 1978-03-24
PH11788A (en) 1978-07-05
IL45644A (en) 1978-03-10
AT336012B (de) 1977-04-12
ATA886374A (de) 1976-08-15
DE2451934C2 (de) 1983-10-06
SE415762B (sv) 1980-10-27
NL7414439A (nl) 1975-05-07
DK136719B (da) 1977-11-14
ZA745751B (en) 1976-04-28
ES431674A1 (es) 1976-11-16
SE7413833L (ko) 1975-05-06

Similar Documents

Publication Publication Date Title
BG26387A3 (bg) Метод за получаване на хексахидро- дибензо/вd/ пиран -9-они
BG21385A3 (bg) Метод за получаване на циклохексанови съединения
SE393172B (sv) Festorgan for langstreckta foremal
RO65649A (ro) Procedeu pentru obtinerea de pirimidine
BG20352A3 (bg) Метод за получаване на пиридил-фенил оксиалкани
RO68025A (ro) Procedeu pentru obtinerea 3-metilmercaptopropionaldehidei
BG21208A3 (bg) Метод за получаване на 1- алилокси-2- хидрокси -3- алкинилами- нопропани
BG21856A3 (bg) Метод за получаване на пиримидин-тионотиолфосфоно-кисели естери
BG22820A3 (bg) Метод за получаване на пиразолони-5
SE405700B (sv) Forfarande for forvermning av former
BG25997A3 (bg) Метод за получаване на 7- ациламидо- 7- метоксицефалоспорини
BG22404A3 (bg) Метод за получаване на а-аминоацил-3-халоцефалоспорини
FI55498B (fi) Foerfarande foer framstaellning av hypoglycemiska pyridinkarboxamid-sulfonylureafoereningar
SE383359B (sv) Stotvagsforma for schaktugn
BG22381A3 (bg) Метод за получаване на диаминобензофенони
BG21849A3 (bg) Метод за получаване на заместени нитробензофенонови производни
BG22823A3 (bg) Метод за получаване на нитромидазолови съединения
BG27092A3 (bg) Метод за получаване на n-фосфонометилглицинови триестери
BG21852A3 (bg) Метод за получаване на бензиламини
SU455915A1 (ru) Способ получени пирониобата свинца
SU469696A1 (ru) Способ получени 5-галоидзамещенных бензопираниндолинов
SU472933A1 (ru) Способ получени меркаптоамидов
RO80846A (ro) Deversor pentru lavabou
BG21223A3 (bg) Метод за получаване на м-диоксан-5-метиламини
BG21853A3 (bg) Метод за получаване на 2-ациламино-бензиламини